Tuberculosis in the cytokine era: What rheumatologists need to know

被引:40
作者
Hamilton, CD [1 ]
机构
[1] Duke Univ, Med Ctr, Durham, NC 27710 USA
来源
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 08期
关键词
D O I
10.1002/art.11134
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2085 / 2091
页数:7
相关论文
共 15 条
[1]  
[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603
[2]  
[Anonymous], 2000, MMWR Recomm Rep, V49, P1
[3]  
[Anonymous], 1997, MMWR Recomm Rep, V46, P1
[4]  
Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8
[5]  
Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P593
[6]  
de Jong R, 1998, SCIENCE, V280, P1435
[7]   TUMOR-NECROSIS-FACTOR-ALPHA IS REQUIRED IN THE PROTECTIVE IMMUNE-RESPONSE AGAINST MYCOBACTERIUM-TUBERCULOSIS IN MICE [J].
FLYNN, JL ;
GOLDSTEIN, MM ;
CHAN, J ;
TRIEBOLD, KJ ;
PFEFFER, K ;
LOWENSTEIN, CJ ;
SCHREIBER, R ;
MAK, TW ;
BLOOM, BR .
IMMUNITY, 1995, 2 (06) :561-572
[8]  
German R R, 2001, MMWR Recomm Rep, V50, P1
[9]  
GIRLING DJ, 1992, AM REV RESPIR DIS, V145, P36
[10]   Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk -: A multicenter active-surveillance report [J].
Gómez-Reino, JJ ;
Carmona, L ;
Valverde, VR ;
Mola, EM ;
Montero, MD .
ARTHRITIS AND RHEUMATISM, 2003, 48 (08) :2122-2127